Results 11 to 20 of about 4,607,099 (394)

Drug prescription support in dental clinics through drug corpus mining [PDF]

open access: yes, 2018
The rapid increase in the volume and variety of data poses a challenge to safe drug prescription for the dentist. The increasing number of patients that take multiple drugs further exerts pressure on the dentist to make the right decision at point-of ...
Goh, Wee Pheng   +5 more
core   +5 more sources

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations

open access: yesFrontiers in Pharmacology, 2021
Pharmacogenomic (PGx) testing has emerged as an effective strategy for informing drug selection and dosing. This has led to an increase in the use of PGx testing in the clinic and has catalyzed the emergence of a burgeoning commercial PGx testing ...
Chad A. Bousman   +5 more
doaj   +1 more source

Helpful, Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on Opioid Prescriptions

open access: yesPharmacoepidemiology, 2023
Prescription drug misuse is a global problem, especially in the United States (US). Clinician involvement is necessary in this crisis, and prescription drug monitoring programs (PDMPs) are a recommended tool for the prevention, recognition, and ...
Nina Z. Y. Smith   +4 more
doaj   +1 more source

“Quantity-effect” research strategy for comparison of antioxidant activity and quality of Rehmanniae Radix and Rehmannia Radix Praeparata by on-line HPLC-UV-ABTS assay

open access: yesBMC Complementary Medicine and Therapies, 2020
Background Quantitation analysis and chromatographic fingerprint of multi-components are frequently used to evaluate quality of herbal medicines but fail to reveal activity of the components.
Hong-Ying Li   +5 more
doaj   +1 more source

Night-shift work and psychiatric treatment. A follow-up study among employees in Denmark

open access: yesScandinavian Journal of Work, Environment & Health, 2022
OBJECTIVES: We aimed to test the hypotheses that night-shift work is associated with an increased incidence of (i) redeemed prescriptions for psychotropic medicine and (ii) psychiatric hospital treatment due to mood, anxiety or stress-related disease ...
Karen Albertsen   +3 more
doaj   +1 more source

Drug related problems. Classification. Prevention methods

open access: yesКардиоваскулярная терапия и профилактика, 2023
The article describes the term “Drug related problems” and the role of its individual components. DRPs can occur at all treatment stages and can be the result of both doctor mistakes in choosing a drug and its dose, indications and contraindications, and
S. Yu. Martsevich
doaj   +1 more source

Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses

open access: yesAnnals of Internal Medicine, 2018
The overuse of prescription opioids during the past 2 decades has evolved into a major public health issue in the United States. Opioid prescribing increased 350% between 1999 and 2015, from 180 to 640 morphine milligram equivalents per capita (1), with ...
David S. Fink   +10 more
semanticscholar   +1 more source

Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages.

open access: yesHealth Affairs, 2018
State prescription drug monitoring programs (PDMPs) aim to reduce risky controlled-substance prescribing, but early programs had limited impact. Several states implemented robust features in 2012-13, such as mandates that prescribers register with the ...
R. Haffajee   +5 more
semanticscholar   +1 more source

Prescription Drug Monitoring Programs and Opioid Overdoses: Exploring Sources of Heterogeneity

open access: yesEpidemiology, 2019
Background: Prescription drug monitoring program are designed to reduce harms from prescription opioids; however, little is known about what populations benefit the most from these programs.
Álvaro Castillo-Carniglia   +9 more
semanticscholar   +1 more source

Crystal structure and anti-inflammatory activity of (E)-7-fluoro-2-((5-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2

open access: yesZeitschrift für Kristallographie - New Crystal Structures, 2021
C17H14FNO2, monoclinic, C2/c (no. 15), a = 15.5754(12) Å, b = 7.4828(6) Å, c = 23.0981(18) Å, β = 90.797(7)°, V = 2691.8(4) Å3, Z = 8, Rgt(F) = 0.0442, wRref(F2) = 0.1096, T = 100(1)° K.
Sun Jia-Jia   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy